Muscle phenotype and mutation load in 51 persons with the 3243A>G mitochondrial DNA mutation

Archives of Neurology

Volumn 63, Issue 12, 2006, Pages 1701-1706

  Jeppesen, Tina D ^a   Schwartz, Marianne ^a   Frederiksen, Anja L ^b   Wibrand, Flemming ^c   Olsen, David B ^a   Vissing, John ^a  

^a Rigshospitalet   (Denmark)

^b ESBJERG HOSPITAL   (Denmark)

^c JOHN F KENNEDY INSTITUTE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

LACTIC ACID; MITOCHONDRIAL DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LACTATE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MITOCHONDRIAL MYOPATHY; MUSCLE BIOPSY; MUSCLE MITOCHONDRION; NUCLEOTIDE SEQUENCE; OXYGEN CONSUMPTION; PATIENT; PHENOTYPE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANAEROBIC THRESHOLD; DIABETES MELLITUS; DNA, MITOCHONDRIAL; FEMALE; GENETIC LOAD; GENOTYPE; GLUCOSE TOLERANCE TEST; HEARING DISORDERS; HUMANS; LACTIC ACID; MALE; MIDDLE AGED; MITOCHONDRIAL DISEASES; MUSCLE, SKELETAL; PHENOTYPE; POINT MUTATION;

EID: 33845528829     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.63.12.1701     Document Type: Article

References (42)

1. Holt IJ, Cooper JM, Morgan-Hughes JA, Harding AE. Deletions of muscle mitochondrial DNA [letter]. Lancet. 1988;1:1462.
2. Wallace DC, Singh G, Lott MT, et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science. 1988;242:1427-1430.
3. Chomyn A, Martinuzzi A, Yoneda M, et al. MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts. Proc Natl Acad Sci U S A. 1992;89:4221-4225.
4. Karppa M, Herva R, Moslemi AR, Oldfors A, Kakko S, Majamaa K. Spectrum of myopathic findings in 50 patients with the 3243A>G mutation in mitochondrial DNA. Brain. 2005;128:1861-1869.
5. Yamamoto M, Clemens PR, Engel AG. Mitochondrial DNA deletions in mitochondrial cytopathies: observations in 19 patients. Neurology. 1991;41:1822-1828.
6. Ciafaloni E, Ricci E, Shanske S, et al. MELAS: clinical features, biochemistry, and molecular genetics. Ann Neurol. 1992;31:391-398.
7. Martinuzzi A, Bartolomei L, Carrozzo R, et al. Correlation between clinical and molecular features in two MELAS families. J Neurol Sci. 1992;113:222-229.
8. Liou CW, Huang CC, Chee EC, et al. MELAS syndrome: correlation between clinical features and molecular genetic analysis. Acta Neurol Scand. 1994;90:354-359.
9. Campos Y, Bautista J, Gutierrez-Rivas E, et al. Clinical heterogeneity in two pedigrees with the 3243 bp tRNA(Leu(UUR)) mutation of mitochondrial DNA. Acta Neurol Scand. 1995;91:62-65.
10. Leu(UUR) A→G(3243) mutation: a clinical and genetic study. Brain. 1995;118:721-734.
11. Mariotti C, Savarese N, Suomalainen A, et al. Genotype to phenotype correlations in mitochondrial encephalomyopathies associated with the A3243G mutation of mitochondrial DNA. J Neurol. 1995;242:304-312.
12. Ozawa M, Goto Y, Sakuta R, Tanno Y, Tsuji S, Nonaka I. The 8344 mutation in mitochondrial DNA: a comparison between the proportion of mutant DNA and clinico-pathologic findings. Neuromuscul Disord. 1995;5:483-488.
13. Chinnery PF, Howell N, Lightowlers RN, Turnbull DM. Molecular pathology of MELAS and MERRF: the relationship between mutation load and clinical phenotypes. Brain. 1997;120:1713-1721.
14. Kiyomoto BH, Tengan CH, Moraes CT, Oliveira AS, Gabbai AA. Mitochondrial DNA defects in Brazilian patients with chronic progressive external ophthalmoplegia. J Neurol Sci. 1997;152:160-165.
15. Uziel G, Moroni I, Lamantea E, et al. Mitochondrial disease associated with the T8993G mutation of the mitochondrial ATPase 6 gene: a clinical, biochemical, and molecular study in six families. J Neurol Neurosurg Psychiatry. 1997;63:16-22.
16. Leu(UUR) A3243G mutation in a MELAS pedigree. Ann Neurol. 2000;47:179-185.
17. Leu(UUR) gene. Arch Dis Child. 2000;82:407-411.
18. Sciacco M, Prelle A, Comi GP, et al. Retrospective study of a large population of patients affected with mitochondrial disorders: clinical, morphological and molecular genetic evaluation. J Neurol. 2001;248:778-788.
19. Carelli V, Baracca A, Barogi S, et al. Biochemical-clinical correlation in patients with different loads of the mitochondrial DNA T8993G mutation. Arch Neurol. 2002;59:264-270.
20. Huang CC, Kuo HC, Chu CC, Liou CW, Ma YS, Wei YH. Clinical phenotype, prognosis and mitochondrial DNA mutation load in mitochondrial encephalomyopathies. J Biomed Sci. 2002;9:527-533.
21. Suomalainen A, Syvanen AC. Quantitative analysis of human DNA sequences by PCR and solid-phase minisequencing. Mol Biotechnol. 2000;15:123-131.
22. Schwartz M, Vissing J. Paternal inheritance of mitochondrial DNA. N Engl J Med. 2002;347:576-580.
23. Wibrand F, Ravn K, Schwartz M, Rosenberg T, Horn N, Vissing J. Multisystem disorder associated with a missense mutation in the mitochondrial cytochrome b gene. Ann Neurol. 2001;50:540-543.
24. Jeppesen TD, Schwartz M, Olsen D, Vissing J. Oxidative capacity correlates with muscle mutation load in mitochondrial myopathy. Ann Neurol. 2003;54:86-92.
25. Taivassalo T, Jensen TD, Kennaway N, DiMauro S, Vissing J, Haller RG. The spectrum of exercise tolerance in mitochondrial myopathies: a study of 40 patients. Brain. 2003;126:413-423.
26. Moraes CT, Schon EA, DiMauro S, Miranda AF. Heteroplasmy of mitochondrial genomes in clonal cultures from patients with Kearns-Sayre syndrome. Biochem Biophys Res Commun. 1989;160:765-771.
27. Larsson NG, Holme E, Kristiansson B, Oldfors A, Tulinius M. Progressive increase of the mutated mitochondrial DNA fraction in Kearns-Sayre syndrome. Pediatr Res. 1990;28:131-136.
28. Weber K, Wilson JN, Taylor L, et al. A new mtDNA mutation showing accumulation with time and restriction to skeletal muscle. Am J Hum Genet. 1997;60:373-380.
29. Hanna MG, Nelson IP, Morgan-Hughes JA, Wood NW. MELAS: a new disease associated mitochondrial DNA mutation and evidence for further genetic heterogeneity. J Neurol Neurosurg Psychiatry. 1998;65:512-517.
30. Chinnery PF, Howel D, Turnbull DM, Johnson MA. Clinical progression of mitochondrial myopathy is associated with the random accumulation of cytochrome c oxidase negative skeletal muscle fibres. J Neurol Sci. 2003;211:63-66.
31. 't Hart LM, Jansen JJ, Lemkes HH, de Knijff P, Maassen JA. Heteroplasmy levels of a mitochondrial gene mutation associated with diabetes mellitus decrease in leucocyte DNA upon aging. Hum Mutat. 1996;7:193-197.
32. Jacobi FK, Leo-Kottler B, Mittelviefhaus K, et al. Segregation patterns and heteroplasmy prevalence in Leber's hereditary optic neuropathy. Invest Ophthalmol Vis Sci. 2001;42:1208-1214.
33. Rahman S, Poulton J, Marchington D, Suomalainen A. Decrease of 3243A→G mtDNA mutation from blood in MELAS syndrome: a longitudinal study. Am J Hum Genet. 2001;68:238-240.
34. Kaplanova V, Zeman J, Hansikova H, et al. Segregation pattern and biochemical effect of the G3460A mtDNA mutation in 27 members of LHON family. J Neurol Sci. 2004;223:149-155.
35. Shiraiwa N, Ishii A, Iwamoto H, Mizusawa H, Kagawa Y, Ohta S. Content of mutant mitochondrial DNA and organ dysfunction in a patient with a MELAS subgroup of mitochondrial encephalomyopathies. J Neurol Sci. 1993;120:174-179.
36. Leu[3243]) in tissues of symptomatic relatives with MELAS: the role of mitotic segregation. Neurology. 1993;43:1586-1590.
37. White SL, Collins VR, Wolfe R, et al. Genetic counseling and prenatal diagnosis for the mitochondrial DNA mutations at nucleotide 8993. Am J Hum Genet. 1999;65:474-482.
38. Damian MS, Seibel P, Reichmann H, et al. Clinical spectrum of the MELAS mutation in a large pedigree. Acta Neurol Scand. 1995;92:409-415.
39. Chinnery PF, Elliott C, Green GR, et al. The spectrum of hearing loss due to mitochondrial DNA defects. Brain. 2000;123:82-92.
40. Uimonen S, Moilanen JS, Sorri M, Hassinen IE, Majamaa K. Hearing impairment in patients with 3243A→G mtDNA mutation: phenotype and rate of progression. Hum Genet. 2001;108:284-289.
41. Van Hall G. Lactate as a fuel for mitochondrial respiration. Acta Physiol Scand. 2000;168:643-656.
42. Jeppesen TD, Olsen D, Vissing J. Cycle ergometry is not a sensitive diagnostic test for mitochondrial myopathy. J Neurol. 2003;250:293-299.